Durvalumab with chemoradiotherapy for limited-stage small-cell lung cancer
Author:
Funder
AstraZeneca
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference32 articles.
1. Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Dingemans;Ann Oncol,2021
2. Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial;Faivre-Finn;Lancet Oncol,2017
3. Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer;Sun;Ann Oncol,2013
4. Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331;Spigel;Ann Oncol,2021
5. Pembrolizumab after two or more lines of previous therapy in patients with recurrent or metastatic SCLC: results from the KEYNOTE-028 and KEYNOTE-158 studies;Chung;J Thorac Oncol,2020
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Pulmonary function and toxicities of proton versus photon for limited-stage small cell lung cancer;Radiation Oncology Journal;2023-12-31
2. Prise en charge des cancers bronchiques à petites cellules de stade localisé, actualisation;Revue des Maladies Respiratoires Actualités;2023-10
3. Small cell lung cancer, current treatment and perspectives;Onkologie;2023-06-16
4. Radiotherapy and Immunotherapy in Lung Cancer;Biomedicines;2023-06-06
5. Combining radiation therapy with immune checkpoint blockade for the treatment of small cell lung cancer;Seminars in Cancer Biology;2023-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3